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Abstract
Introduction and hypothesis This study aims to answer the
question, “Does tissue augmentation improve the mechanical
repair of displacement cystourethrocoele?”
Methods A retrospective cohort study comparing 108 bridg-
ing graft vaginal paravaginal repairs (89 tissue-inductive
xenografts and 19 polypropylene mesh) to 59 native tissue
historical controls was conducted. Main outcome measures
were same-site prolapse recurrence and time to failure. Initial
reliability was evaluated by chi-squared test, 10-year dura-
bility by Kaplan–Meier survival analysis and risk factors by
Cox regression.
Results Late recurrence was 17.7% lower with augmentation
(logrank test χ
2=8.4, p value=0.0038<0.05, adjusted
regression analysis χ
2=2.94; p value=0.0866 <0.10), impli-
cating collagen degeneration in repair failure.
Conclusions Rebuilding the pubocervical septum, from arcus
to arcus and pubic ramus to pericervical ring, satisfies the
mechanical but not the metabolic hernia principles. Bridging
grafts simplify technical repair (reducing prolapse persistence
from 10.2% to 4.6%), and also rejuvenate adjacent connective
tissue (reducing late recurrence from 22.6% to 4.9%).
Keywords Connective tissue pathology.Cystocoele
aetiology.Hernia/therapy.Reconstructive surgical
procedures/pelvis/methods.Tissue engineering
bioprosthesis.Vaginal paravaginal repair/treatment
outcome
Introduction
Pelvic floor disorders are a cluster of urinary, sexual or
defaecation problems that arise mainly out of structural
damage or neuromuscular disruption to the pelvic floor,
rather than through any malfunction of the specific organs
themselves. One in two parous women (versus one in ten
men) experiences some type of pelvic floor disorder during
her lifetime. At entry examination, 41% of the participants
in the Women’s Health Initiative study had clinically
significant prolapse [1]. Anterior vaginal wall was the most
commonly affected segment. Fifty-five percent of subjects
had a dominant single bulge and another 20% had a
cystocoele as part of a diffuse pattern of support failure.
This is important because cystocoele repair is relatively
unsuccessful. However, pelvic surgeons are seldom con-
fronted with their own operative failures; women tend to
suffer in silence, or seek referral elsewhere. Nonetheless,
29% of the 150,000 insured women at Kaiser Permanente
North West in 1995 needed at least one repeat surgery [2].
Applying an epidemiologic “rule of thumb” from the hernia
literature, that another 40% of failures would not have
returned [3], overall success rate was perhaps ~60%.
Historically, case series reporting on plication-type cysto-
coele repair claimed success rates around 75–100%. More
rigorous examination in recent randomised controlled
trials has shown anterior colporrhaphy to be less effective
than previously believed. Two recent RCTs report ana-
Part I of this article can be found at DOI 10.1007/s00192-010-1347-2.
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2y e a r s[ 5]. Prevalence of pelvic floor disorders increases
in a linear fashion with age [6] but consultations for pelvic
floor disorders have a Gaussian distribution [7], suggest-
ing that many women over 60 years lose faith in the
treatments offered and hence no longer attend.
Cystocoele repair has been problematic for several
reasons [8]. Pelvic anatomy is complex, difficulty increases
with time and tissue weakness, and reparative efforts have
been confounded by 100 years of mechanically misdirected
surgical strategies. In normal women, the pubovisceral
muscles compensate pressure-induced stress on the mid-
vaginal fascial supports by narrowing the genital hiatus,
while the levator plate acts as a dynamic backstop to
dissipate Valsalva forces. Net effect is that the pelvic floor
muscles absorb most of the expulsive load on the pelvic
organs, and it is very difficult for the body to compensate
any muscle damage. Endopelvic fascia is also important,
but in a less direct way. Pelvic connective tissue is basically
an embryologic mesentery, which tethers the pelvic viscera
to the axial skeleton. Its main suspensory role is to stabilise
the organs over the posterior levator plate, where the pelvic
floor muscles work most effectively. Given that muscle
damage sustained at childbirth is not presently reparable,
our strategies for re-suspending the sagging pelvic organs
depend unduly on connective tissue strength. Unfortunately,
endopelvic fascia is not structurally suited to chronic load-
bearing, making the task of prolapse repair intrinsically
difficult. Any connective tissue weakness would be
expected to exacerbate this inherent flaw, potentially under-
mining even the most skillful traditional repair. Experience
accrued by herniologists in averting healing failure due to
collagen weakness might therefore have useful lessons for
the pelvic reconstructive surgeon.
Retrospective analysis of an 11-year database showed
sutured vaginal paravaginal repair (VPVR) to be a
genuinely curative treatment for severe displacement
cystocele. Whether a 69.5% success rate from native tissue
vaginal VPVR truly justifies the additional surgical effort
involved in paravaginal repair instead of anterior colpor-
rhaphy (as a palliative treatment) or mesh-augmented
paravaginal repair (as a more robust curative procedure) is
debatable. General surgeons have identified connective
tissue weakness adjacent to the suture lines as an important
factor in failed hernia repair (discussed at length elsewhere)
[8]. There is evidence that collagen weakness sometimes
develops in longstanding prolapse, raising the question of
whether pelvic reparative strategies should also address
this phenomenon. We hypothesised that measures to
strengthen the central fascia of the anterior vaginal wall
trapezoid would improve repair durability, over and above
what was attainable by site-specific repair of the causative
fascial defects.
Methods
Study design is a retrospective cohort analysis of augmented
versus native tissue VPVRs. The cohorts were generated
from a database of 275 consecutive site-specific prolapse
repairs over an 11-year period (1997–2007). Data collection
was regarded as a quality assurance project, and therefore
exempted from Human Research Ethics Committee review.
In all, there were 59 native tissue repairs and 108 tissue-
augmented VPVRs. The key date with respect to treatment
assignment was January 2004, when the first tissue-inductive
biomesh (Surgisis ES
®: Cook Medical Incorporated, Bloo-
mington, IN) was licensed in Australia. Prior to this date,
VPVR was done by re-suture of native tissues using the
“three point” technique. After January 2004, sutured VPVR
was abandoned in favour of a bridging graft technique.
Surgisis ES
® was the favoured graft in most privately insured
women and some public cases (89 women). In the synthetic
mesh subgroup, a relatively lightweight monofilament,
macroporous polypropylene knit (Gynemesh
®: Ethicon,
Somerville, NJ) was used in 15 women and a hernia weight
Amid class I knit (Marlex
®, CR Bard Inc, Murray Hill, NJ)
was used in four women. These four Marlex
® cases were
treated before 2002 (i.e., prior to the availability of prolapse-
specific polypropylene meshes). Hernia weight mesh was
used to forestall an extreme risk of poor outcome, these four
women having failed a total of 16 previous sutured prolapse
repairs. Despite differences in mesh weight, we included
these four Marlex
® cases in the augmentation group. There is
no evidence that differences in mesh weight materially
impact repair outcome [8]. All four had a successful
anatomic outcome, but the mesh had to be removed in two
women. Omitting the Marlex
® cases would have made our
results appear more favourable than they actually were.
Primary measures of outcome were: same site (anterior
segment) prolapse recurrence, time to failure and any
significant surgical complication. Secondary measures of
outcome were different sites (postero-apical segment),
anatomic recurrence and persistent or de novo pelvic organ
dysfunction. In that data collection began before POPQ
staging had become widely established, anatomic outcome
w a sg a u g e db yt h eB a d e nW a l k e r“halfway” system.
Objective anatomic success was defined as either ideal
support (B-W stage 0) or mild laxity (B-W stage 1).
Functional success was determined from answers to a
symptom inventory, completed at presentation and at yearly
follow-up. Mean follow-up time was 55 months (range=4–
120 months) for native tissue and 23 months (range=3–
44 months) for augmented cases.
Statistical analysis examined short-term reliability and
long-term durability of cystocele repair. The reliability with
which an effective mechanical repair had been achieved
initially was gauged at the 6-month postoperative visit,
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sion. Long-term anatomical durability of an initially
successful repair was examined with the Kaplan–Meier
survival curves and log rank test, then further evaluated
using the Cox proportional hazards model.
Results
Group comparison (using chi-squared test) showed no
statistical difference in the distribution of potentially con-
founding variables including age, body mass index (BMI)
>25 kg/m
2, ≥ stage III descensus, prior or concomitant
hysterectomy, prior failed surgery, severe urinary inconti-
nence or suspected collagen weakness (p values>0.05),
except for multi-compartment repair (χ
2=10.324, p value=
0.003; Table 1). Given that the primary surgical philosophy
was to “leave the entire tract intact” after the index
operation, overt or incipient apical support weakness was
repaired in 146 subjects (21 by uterosacral ligament
culdoplasty and 125 by sacrospinous ligament fixation).
Prolapse recurrence in the group needing only cystocele
repair did not differ significantly from that when concom-
itant culdoplasty or sacrospinous ligament fixation was
performed [six of 21 (71%) vs five of 21 (76%) vs 17 of 125
(86%); χ
2=3.742, p value=0.309>0.05].
Vaginal paravaginal repair (VPVR) by either technique
exhibited genuine curative potential for cystocoele, as
evidenced by absolute flattening of the Kaplan–Meier
survival curve at 20 months in the augmented group and
at 38 months in the native tissue group (Fig. 1). The
likelihood of restoring normal anterior compartment anat-
omy at 6 months was unaffected by use of a bridging graft
[103 of 108 (95.4%) vs 53 of 59 (89.8%); χ
2=1.903,
p value=0.292>0.05]. However, twelve sutured VPVRs
failed over the succeeding 32 months (three at 7–12 months;
four at 13–24 months; four at 25–36 months and one at 37–
48 months), reducing 10-year success rate to 69.6%. In
contrast, there were only five late augmentation failures—
two at 6–12 months and three at 13–24 months (Table 2).
Cumulative probability of objective anatomic success was
0.94 at 1 year and 0.91 at 2, 3, and 4 years in the
augmented group versus 0.85 at 1 year and 0.78, 0.71 and
0.69 at 2, 3, and 4 years after native tissue repair,
respectively. Logrank test confirmed that this divergence
of survival analysis curves over time was statistically
significant (χ
2=8.4, p value=0.0038<0.05). Augmented
repair also appeared superior by unadjusted regression
analysis (χ
2=4.24; p=0.0395<0.05). But adding age,
patient domicile and multi-compartment repair outcomes
to the Cox proportional hazards model slightly changed the
hazards ratio (from 0.430 to 0.465), and the difference
between groups was only significant at the 10% level
(p=0.0866<0.10; Table 3). All potential confounder vari-
ables had high p values and wide 95% confidence intervals
that crossed unity by a large margin, implicating the dual
effect of small sample size and high censoring as major
contributory factors. The impact of selection bias in this
study is difficult to establish because of the non-random
treatment assignment.
Both surgical techniques relieved bulge discomfort, with
augmented VPVR being somewhat better (Table 4a).
Seventy-six percent of women either remained or were
rendered dry to mechanical provocation following VPVR,
with a weak trend in favour of the augmentation group
(Table 4b). Thirteen women with persisting stress urinary
incontinence opted for bulking injection or mid-urethral
sling placement as a follow-up procedure. ‘Overactive
bladder wet’ symptoms were resolved or greatly ameliorated
in 56% of the 109 women who had urge urinary inconti-
nence at presentation. There was a trend in favour of
augmented VPVR, falling just short of p=0.05 (Table 4c).
Finally, pre-existing dyspareunia was resolved in 13 of 21
augmented VPVR and in three of eight native tissue repairs;
however, six individuals in the first and two in the second
group developed de novo dyspareunia (largely attributable to
the use of synthetic mesh). This represented a 28% decrease
in the overall dyspareunia rate (from 29 to 21 complainants).
Anatomic outcome appeared to improve with tighter
conformity to the hernia principles (Table 5). Suture-only
paravaginal repair was successful in only 41of 59 (69.5%)
at 10 years. Augmentation with synthetic mesh delivered
almost perfect anatomic outcomes, but the polypropylene
had to be removed in three of 19 women—reducing
ultimate success rate to 84.2%. Best performing biomaterial
proved to be Surgisis
® ES (Cook Medical Incorporated,
Bloomington, IN). Surgisis
® ES is an acellular lyophilized
xenograft harvested from porcine small intestinal submu-
cosa and fabricated into a strong 4-ply multilaminate.
Second-generation biologicals like Surgisis
® ES have
tissue-inductive properties not found in denatured xeno-
grafts [9]. The robust capacity for constructive remodelling
yielded anatomic success in 82 of 89 (92.1%) women, and
rapid bio-absorption of the implanted xenograft (usually
within 3 months) protected against mesh morbidity.
Overall, there were eight (4.8%) perioperative surgical
complications—three (5.1%) occurring in the 59 native tissue
group and five (4.6%) in the 108 augmented repairs. While
there was no statistical difference between these small
numbers, it is a surgical reality that the use of a bridging graft
made the operation of vaginal paravaginal repair quicker and
easier to perform. None of these adverse events were unique
to the operative technique. Of the dissection-related surgical
complications, there were two pelvic hematomas and one
transient ureteral obstruction (from swelling of adjacent
tissues). There were two (50%) mesh-related complications
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® implants (one vaginal
pain lasting 3 years and one vesico-vaginal fistula occurring
after 6 years) and one (6.7%) mesh-related complications
among the 15 women who had Gynemesh
® implants (a mesh
contracture). No biomaterial-related problems were seen in
the 89 women having Surgisis ES
® implants.
Discussion
Our null hypothesis was that strengthening the central fascia
of the anterior vaginal wall trapezoid would not further
improve repair durability, over and above what was
attainable by re-suture of the causative fascial avulsions.
Study results refute this null hypothesis. Use of any form of
augmentation significantly outperformed native tissue
VPVR, as shown in Fig. 1 [χ
2=8.4, p value=0.0038<
0.05]. Similar results from augmented VPVR have been
published elsewhere. Simsiman et al. [10] reported a 78% 2-
year success with cross-linked porcine dermis (Pelvicol
®:C R
Bard, Murray Hill, NJ) and Clemons [11] reported a 59% 4-
year success with cadaveric human dermis (Alloderm
®:
Boston Scientific, Natick, MA), a second-generation graft.
The use of implanted materials to re-enforce sagging
pelvic support is intuitively logical. Biomaterials (particu-
larly trocar-driven mesh kits) are being used with increasing
frequency—despite a paucity of long-term supportive data
and the growing safety concerns reported in several
systematic reviews [12–15]. The main strength of our study
is that we measured the impact of tissue augmentation
materials on site-specific native tissue repair over an
adequate observation period (5 years). Another strong point
is that this study evaluated tissue-inductive xenografts as
opposed to the now obsolete first-generation biological
implants. Given that minimally altered and chemically
adulterated xenografts evoke completely different host
immune responses, it is erroneous to combine these two
products into a single classification category [9]. This
information is well-known to biomaterials scientists, but
poorly reported in the medical literature. Like all retrospec-
tive investigations, this article has limitations. By the
middle of the study period, the first author had become
dissatisfied with the “return on effort” from native tissue
VPVR. At about this time, two new augmentation materials
gained regulatory approval in Australia—Gynemesh
® (a
flexible light weight synthetic mesh, better suited to
prolapse repair) and Surgisis
® ES (a tissue-inductive
xenograft). In January 2004, surgical technique was
therefore changed from sutured repair to a bridging graft
Fig. 1 Ten-year Kaplan–Meier survival analysis data comparing
augmented versus native tissue VPVR. The use of any form of
augmentation was significantly better than suture-only repair [logrank
χ
2=4.48, p value=0.0343<0.05]. Late failures may have continued
for longer in the native tissue group, but the heavy censoring of the
augmented group must also be taken into account. Nonetheless, both
curves eventually flattened—augmented repair at about 19 months and
sutured VPVR at about 38 months. These results suggest that the
remaining women had obtained a durable cystocoele repair
Table 1 Group comparison of baseline demographics and potentially confounding factors
Baseline demographics and potential
confounders
Augmented vaginal paravaginal
repair
Native tissue vaginal paravaginal
repair
P value
Mean age 60.5 years 61.9 years 0.309 (n.s.)
Multi-compartment prolapse 101/108 (93.5%) 45/59 (76.3%) 0.003 (sig.)
Concomitant hysterectomy 25/108 (23.1%) 14/59 (23.7%) 0.932 (n.s.)
Prior hysterectomy 45/108 (41.7%) 26/59 (44.1%) 0.764 (n.s.)
Prior failed surgery 41/108 (38.0%) 20/59 (33.9%) 0.602 (n.s.)
Suspected collagen weakness 30/108 (27.8%) 13/59 (22.0%) 0.417 (n.s.)
≥ Stage 3 descensus 79/108 (73.1%) 44/59 (74.6%) 0.841 (n.s.)
Severe incontinence 34/108 (31.5%) 23/59 (39.0%) 0.328 (n.s.)
BMI>25 kg/m
2 70/108 (64.8%) 41/59 (69.5%) 0.541 (n.s.)
sig. significant, n.s. not significant
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® ES was more expensive than
Gynemesh
®, meaning that choice of mesh was sometimes
influenced by patient insurance status. It has been learned
in hernia surgery that mesh weight, material stiffness and
weave/knit construction must suit the tissue resilience and
the degree of movement expected at the graft–host
interface. Medium-weight macroporous monofilament
polypropylene meshes have worked well in groin hernia
repair; but when implanted into the more mobile tissues of
a ventral hernia, their torsional rigidity can cause bother-
some abdominal wall stiffness [8]. Given that Marlex and
Gynemesh are both polypropylene meshes of similar
construction (i.e., macroporous monofilament knits), the
four women implanted with a hernia weight mesh before
2002 were analysed as a single “synthetic mesh” group.
Studies to date have not demonstrated that a reduction in
mesh weight delivers lower morbidity [9]. This decision
was taken because their omission would have spuriously
elevated the relative success of bridging graft VPVR, from
98 of 108 (90.7%) to 96 of 104 (92.3%), as well as omitting
the worst of our surgical complications (a mesh-induced
vesico-vaginal fistula).
Breaking the stubborn cycle of prolapse recurrence will
require an improved understanding of the precise mecha-
nism(s) of failure. Was the site-specific repair unable to
secure a sound repair of the existing mechanical defects, or
did an initially successful operation subsequently break
down due to biochemical weakness in the pelvic connective
Int Urogynecol J (2011) 22:601–609 605
Table 2 Time to failure in the 28 unsuccessful repairs
Procedure Failure pattern Total
failures
Number in
group
≤6 months 6–12
months
13–24
months
25–36
months
37–48
months
≥48 months
Native tissue group
Native tissue VPVR 6 3 4 4 1 0 18 59
Augmented group
Gynemesh
® or Marlex
®
augmentation
3
a 0000 0 3 1 9
Surgisis
® augmentation 2 2 3 0 0 0 7 89
Combined augmentation group 5 2 3 0 0 0 10 108
Total 11 5 7 4 1 0 28 167
aMesh was removed from three cases (one for chronic pain, one for contracture, one for vesico-vaginal fistula). Each of these cases was counted here as a
‘technical failure’ rather than as a ‘technical success with an accompanying complication’
Table 3 Cox regression analyses of long-term outcome before (A) and after (B) adjusting for the possible confounders
Analysis of maximum likelihood estimates
Variable Parameter
estimate
Standard
error
Wald chi-
squared
P value Hazard
ratio
95% hazard
range ratio
Cox regression: before adjusting for multisegment prolapse
Survival difference between augmented & native
tissue VPVR
−0.8429 0.4093 4.242 0.0395
a 0.430 0.193 0.960
Cox regression: after adjusting for patient age, domicile and multi-compartment repair
Augmented versus native tissue VPVR −0.7651 0.4465 2.9363 0.0866
b 0.465 0.194 1.116
Comparing 45–65 year with <45 years age group 0.3638 0.5965 0.3721 0.542 1.439 0.447 4.632
Comparing >65 year with <45 years age group 0.2379 0.6053 0.1545 0.694 1.269 0.387 4.155
Sydney distant domicile vs Sydney local −0.5881 0.6562 0.8030 0.370 0.555 0.153 2.010
Rural domicile vs Sydney local −0.1614 0.4624 0.1219 0.727 0.851 0.344 2.106
Rural domicile vs Sydney distant −0.7051 0.7734 0.8312 0.362 0.494 0.109 2.250
Multi-compartment relapse vs single site −0.3888 0.499 0.6062 0.436 1.475 0.554 3.925
aSignificance level of 5% was used here
bSignificance weakened to the 10% significance level because of small sample size and heavy censoring in years 3, 4 and 5tissues? Looking at 6-month follow-up (a reasonable
surrogate for persistence, as opposed to recurrence) [9,
16], initial failure rate was comparable in the two groups
[103 of 108 (95.4%) vs 53 of 59 (89.8%); χ
2=1.903, p
value=0.292>0.05]. This observation suggests that both
sutured and bridging graft repair were effective methods for
overcoming the perennial technical difficulty of locating
and mobilising the torn fascial edges. Thereafter, there were
five additional failures in the augmented group and 12 in
the native tissue group. Delayed failures are a reasonable
surrogate for recurrence, as opposed to persistence. That
late recurrence was 17.7% lower in the augmented group
[five of 103 (4.9%) versus 12 of 53 (22.6%); logrank test
χ
2=8.4, p value=0.0038<0.05, unadjusted regression
analysis χ
2=4.24; p value=0.0395<0.05 and adjusted
regression analysis χ
2=2.94; p value=0.0866<0.10] sug-
gests that deterioration in collagen quality within the
chronically prolapsed bladder hammocks may be a second
important factor in repair failure (Fig. 1). Obtaining an ideal
outcome would appear to depend upon correcting both
failure mechanisms. This situation is not dissimilar to the
problems that general surgeons face with hernia repair.
Hernia is the protrusion of an internal organ (usually
small intestine) through a weakness in the abdominal wall.
Formation reflects both a mechanical and a metabolic event
[8, 16]. The mechanical event can be a congenital weakness
at the internal ring or a traumatic/post-incisional break in
the transversalis fascia. Any protruding tongue of peritone-
um generally remains subclinical for years; however,
progression to symptomatic hernia becomes likely if
abdominal wall muscle strength can no longer contain the
forces generated during Valsalva straining or at loading of
the torso during heavy exertion. Hernia formation is also
favoured by any metabolic compromise of the adjacent
connective tissue quality—either genetic [8] or acquired
[17]. Somewhat analogous to hernia, cystocoele is a
protrusion of the vesical neck and/or bladder base through
a site-specific tear in the fascial envelope of the vagina.
Progression from subclinical support damage to symptom-
atic prolapse takes decades, and is largely driven by the
operation of diverse secondary events [8].
Over the course of two centuries, general surgeons have
developed a set of operative rules to minimise the
contribution of mechanical factors to failed hernia repair
(Table 4). The cardinal rule was to repair all site-specific
fascial defects, sewing identical tissue within the same
layer, using interrupted stitches of permanent suture,
without undue suture line tension in any direction. It was
also traditional to re-secure the abdominal connective
tissues to the axial skeleton by sewing the conjoint tendon
to the inguinal ligament. These manoeuvres were broadly
successful, but excessive wound tension sometimes imped-
ed healing. Some 25 years ago, surgeons turned to mesh
implants as the best way of reducing wound tension and
postoperative pain [18]. Such a strategy also made repair of
the mechanical defect technically easier and serendipitously
reinforced any weakness in the adjacent connective tissues.
The key question is whether gynaecologists should adopt
these surgical rules, at least at a theoretic level [8]. Results
from this study appear to support that contention. Success
rates for prolapse repair improved with increasing adher-
ence to the hernia principles. Anterior colporrhaphy meets
none of these rules, and is predictably inferior [4, 5]. Native
tissue VPVR satisfies the criterion of being a site-specific
technique, analogous to a Bassini or Shouldice hernia
repair. However, all sutured repairs increase wound tension,
and any adjacent collagen weakness remains unresolved.
Bridging graft repair is exactly analogous to modern
prosthetic hernioplasty; it is completely tension-free and
carries the added advantage of simplifying the operative
Surgical technique Relevant symptom Total
Resolved Failed
Symptom control in the 144 women with bulge discomfort (χ
2=5.43; p value=0.02<0.05)
Augmented VPVR 86 (93.5%) 6 92
Native tissue VPVR 42 (80.8%) 10 52
Total 128 16 144
a
Ultimate stress urinary incontinence status within the entire sample (χ
2=2.15; p value=0.14>0.05)
Augmented VPVR 86 (79.6%) 22 108
Native tissue VPVR 41 (69.5%) 18 59
Total 127 40 167
Ultimate symptom control in 109 women with overactive bladder wet (χ
2=3.68; p value=0.06>0.05)
Augmented VPVR 45 (62.5%) 27 72
Native tissue VPVR 16 (43.2%) 21 37
Total 61 48 109
b
Table 4 Effect of surgical re-
pair on bulge, stress urinary
incontinence and overactive
bladder wet symptoms
a Twenty-three of the 167 women
did not complain of bulge dis-
comfort, reducing subject number
to 144
bFifty-eight of the 167 women did
not complain of bulge discomfort,
reducing subject number to 109
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a
-
a
b
d
o
m
i
n
a
l
p
r
e
s
s
u
r
e
S
u
r
g
e
o
n
s
o
f
t
h
e
e
a
r
l
y
1
9
t
h
c
e
n
t
u
r
y
l
i
g
a
t
e
d
t
h
e
h
e
r
n
i
a
l
s
a
c
a
t
t
h
e
e
x
t
e
r
n
a
l
r
i
n
g
,
p
e
r
h
a
p
s
s
a
c
r
i
f
i
c
i
n
g
t
h
e
t
e
s
t
i
c
l
e
.
T
h
e
h
e
r
n
i
a
l
b
u
l
g
e
w
a
s
r
e
d
u
c
e
d
b
y
i
m
b
r
i
c
a
t
i
o
n
o
f
t
h
e
e
x
t
e
r
n
a
l
o
b
l
i
q
u
e
a
p
o
n
e
u
r
o
s
i
s
,
s
o
m
e
w
h
a
t
a
n
a
l
o
g
o
u
s
t
o
c
u
l
d
o
p
l
a
s
t
y
a
n
d
p
l
i
c
a
t
i
o
n
r
e
p
a
i
r
o
f
p
r
o
l
a
p
s
e
.
F
o
u
r
-
y
e
a
r
r
e
c
u
r
r
e
n
c
e
r
a
t
e
s
a
p
p
r
o
a
c
h
e
d
1
0
0
%
,
a
n
d
t
h
i
s
s
t
r
a
t
e
g
y
w
a
s
s
o
o
n
a
b
a
n
d
o
n
e
d
.
H
o
w
e
v
e
r
,
w
h
e
n
s
u
r
g
e
o
n
s
l
e
a
r
n
e
d
h
o
w
t
o
d
i
s
s
e
c
t
t
h
e
i
n
g
u
i
n
a
l
c
a
n
a
l
s
a
f
e
l
y
,
t
h
e
s
e
c
o
n
c
e
p
t
s
e
v
o
l
v
e
d
i
n
t
o
m
o
r
e
s
e
c
u
r
e
t
e
c
h
n
i
q
u
e
s
(
l
i
g
a
t
i
n
g
t
h
e
h
e
r
n
i
a
l
s
a
c
a
t
t
h
e
i
n
t
e
r
n
a
l
r
i
n
g
a
n
d
n
a
r
r
o
w
i
n
g
t
h
e
i
n
t
e
r
n
a
l
/
e
x
t
e
r
n
a
l
r
i
n
g
s
)
.
R
e
p
a
i
r
t
e
a
r
s
i
n
i
n
v
e
s
t
i
n
g
f
a
s
c
i
a
I
n
1
8
8
7
,
B
a
s
s
i
n
i
c
o
n
c
e
i
v
e
d
o
f
a
g
e
n
u
i
n
e
l
y
c
u
r
a
t
i
v
e
h
e
r
n
i
a
o
p
e
r
a
t
i
o
n
,
a
n
a
l
o
g
o
u
s
t
o
s
i
t
e
-
s
p
e
c
i
f
i
c
p
r
o
l
a
p
s
e
r
e
p
a
i
r
.
I
n
s
t
e
a
d
o
f
o
b
l
i
t
e
r
a
t
i
n
g
t
h
e
i
n
g
u
i
n
a
l
c
a
n
a
l
,
B
a
s
s
i
n
i
r
e
s
t
o
r
e
d
t
h
e
p
h
y
s
i
o
l
o
g
i
c
a
l
f
l
a
p
v
a
l
v
e
m
e
c
h
a
n
i
s
m
o
f
t
h
e
n
o
r
m
a
l
g
r
o
i
n
.
T
h
e
r
e
w
e
r
e
t
w
o
e
s
s
e
n
t
i
a
l
d
i
c
t
a
t
e
s
:
m
o
b
i
l
i
s
i
n
g
t
h
e
f
a
s
c
i
a
t
r
a
n
s
v
e
r
s
a
l
i
s
t
o
r
e
-
c
r
e
a
t
e
a
s
t
r
o
n
g
i
n
g
u
i
n
a
l
f
l
o
o
r
a
n
d
r
e
-
e
n
f
o
r
c
i
n
g
t
h
e
r
o
o
f
b
y
s
u
t
u
r
i
n
g
t
h
e
c
o
n
j
o
i
n
t
t
e
n
d
o
n
(
u
n
d
e
r
t
e
n
s
i
o
n
)
t
o
t
h
e
i
n
g
u
i
n
a
l
l
i
g
a
m
e
n
t
.
T
h
e
s
e
c
o
n
c
e
p
t
s
h
a
v
e
e
v
o
l
v
e
d
t
o
t
h
e
m
a
i
n
s
t
a
y
o
f
t
r
a
d
i
t
i
o
n
a
l
h
e
r
n
i
a
p
r
i
n
c
i
p
l
e
s
:
n
a
m
e
l
y
,
t
o
s
e
w
i
d
e
n
t
i
c
a
l
t
i
s
s
u
e
w
i
t
h
i
n
t
h
e
s
a
m
e
l
a
y
e
r
,
u
s
i
n
g
i
n
t
e
r
r
u
p
t
e
d
s
t
i
t
c
h
e
s
o
f
p
e
r
m
a
n
e
n
t
s
u
t
u
r
e
,
w
i
t
h
o
u
t
u
n
d
u
e
s
u
t
u
r
e
l
i
n
e
t
e
n
s
i
o
n
i
n
a
n
y
d
i
r
e
c
t
i
o
n
.
H
o
w
e
v
e
r
,
r
e
-
a
p
p
r
o
x
i
m
a
t
i
o
n
o
f
t
o
r
n
t
i
s
s
u
e
s
i
n
h
e
r
n
i
a
o
r
p
r
o
l
a
p
s
e
r
e
p
a
i
r
a
l
w
a
y
s
p
r
o
d
u
c
e
s
w
o
u
n
d
t
e
n
s
i
o
n
,
r
e
g
a
r
d
l
e
s
s
o
f
h
o
w
w
e
l
l
t
h
e
o
p
e
r
a
t
i
o
n
i
s
d
o
n
e
.
R
e
-
a
n
c
h
o
r
t
h
e
t
o
r
n
i
n
v
e
s
t
i
n
g
f
a
s
c
i
a
b
a
c
k
o
n
t
o
s
k
e
l
e
t
o
n
I
n
a
d
d
i
t
i
o
n
t
o
r
e
p
a
i
r
i
n
g
t
h
e
t
e
a
r
s
w
i
t
h
i
n
t
r
a
n
s
v
e
r
s
a
l
i
s
f
a
s
c
i
a
,
s
u
r
g
e
o
n
s
a
l
s
o
l
e
a
r
n
e
d
t
o
c
i
r
c
u
m
v
e
n
t
i
n
f
e
r
o
-
m
e
d
i
a
l
r
e
c
u
r
r
e
n
c
e
s
b
y
s
t
i
t
c
h
i
n
g
t
h
e
m
e
d
i
a
l
p
a
r
i
e
t
a
l
w
a
l
l
o
f
B
a
s
s
i
n
i
’
s
r
e
p
a
i
r
o
n
t
o
e
i
t
h
e
r
i
n
g
u
i
n
a
l
o
r
C
o
o
p
e
r
’
s
l
i
g
a
m
e
n
t
.
T
h
i
s
s
t
r
a
t
e
g
y
i
s
a
n
a
l
o
g
o
u
s
t
o
p
a
r
a
v
a
g
i
n
a
l
r
e
p
a
i
r
o
f
a
c
y
s
t
o
c
e
l
e
.
P
r
i
n
c
i
p
l
e
s
o
f
t
e
n
s
i
o
n
-
f
r
e
e
m
e
s
h
r
e
p
a
i
r
T
e
n
s
i
o
n
-
f
r
e
e
h
e
r
n
i
a
r
e
p
a
i
r
w
a
s
f
i
r
s
t
u
s
e
d
t
o
r
e
d
u
c
e
s
u
t
u
r
e
l
i
n
e
t
e
n
s
i
o
n
,
b
u
t
s
e
r
e
n
d
i
p
i
t
o
u
s
l
y
d
e
l
i
v
e
r
e
d
t
h
e
b
e
n
e
f
i
t
o
f
t
i
s
s
u
e
a
u
g
m
e
n
t
a
t
i
o
n
I
s
o
l
a
t
e
m
e
s
h
f
r
o
m
c
o
n
t
a
c
t
w
i
t
h
a
h
o
l
l
o
w
v
i
s
c
u
s
P
l
a
c
i
n
g
a
l
l
o
p
l
a
s
t
i
c
m
e
s
h
i
n
p
r
o
x
i
m
i
t
y
c
a
r
r
i
e
s
a
r
i
s
k
o
f
l
a
t
e
e
n
t
e
r
o
-
c
u
t
a
n
e
o
u
s
f
i
s
t
u
l
a
.
H
e
n
c
e
,
p
r
o
x
i
m
i
t
y
t
o
a
n
y
h
o
l
l
o
w
v
i
s
c
u
s
m
a
n
d
a
t
e
s
e
i
t
h
e
r
a
c
o
m
p
o
s
i
t
e
s
y
n
t
h
e
t
i
c
m
e
s
h
(
w
i
t
h
a
n
o
n
-
a
d
h
e
s
i
v
e
b
a
r
r
i
e
r
)
o
r
a
‘
s
e
c
o
n
d
g
e
n
e
r
a
t
i
o
n
’
b
i
o
l
o
g
i
c
a
l
.
L
i
m
i
t
b
a
c
t
e
r
i
a
l
c
o
l
o
n
i
s
a
t
i
o
n
o
f
t
h
e
m
e
s
h
M
u
l
t
i
f
i
l
a
m
e
n
t
p
o
l
y
e
s
t
e
r
m
e
s
h
e
s
a
r
e
‘
w
e
t
t
a
b
l
e
’
—
l
e
a
d
i
n
g
t
o
s
o
f
t
e
r
s
c
a
r
r
e
a
c
t
i
o
n
s
,
b
u
t
a
h
e
i
g
h
t
e
n
e
d
r
i
s
k
o
f
g
r
a
n
u
l
o
m
a
t
o
u
s
i
n
f
e
c
t
i
o
n
,
i
f
c
o
l
o
n
i
s
e
d
b
y
b
a
c
t
e
r
i
a
.
C
o
n
v
e
r
s
e
l
y
,
m
o
n
o
f
i
l
a
m
e
n
t
p
o
l
y
p
r
o
p
y
l
e
n
e
m
e
s
h
i
s
‘
n
o
n
-
w
e
t
t
a
b
l
e
’
—
l
e
a
d
i
n
g
t
o
h
a
r
d
e
r
s
c
a
r
f
o
r
m
a
t
i
o
n
,
b
u
t
a
p
a
r
t
i
a
l
r
e
s
i
s
t
a
n
c
e
t
o
b
a
c
t
e
r
i
a
l
c
o
l
o
n
i
s
a
t
i
o
n
.
P
o
l
y
e
s
t
e
r
i
s
a
b
s
o
l
u
t
e
l
y
c
o
n
t
r
a
i
n
d
i
c
a
t
e
d
i
n
a
n
y
t
h
i
n
g
o
t
h
e
r
t
h
a
n
a
c
l
e
a
n
w
o
u
n
d
.
P
o
l
y
p
r
o
p
y
l
e
n
e
c
a
n
b
e
p
l
a
c
e
d
i
n
a
c
l
e
a
n
c
o
n
t
a
m
i
n
a
t
e
d
f
i
e
l
d
,
b
u
t
l
a
t
e
m
e
s
h
i
n
f
e
c
t
i
o
n
m
a
y
o
c
c
u
r
.
H
o
w
e
v
e
r
s
e
c
o
n
d
g
e
n
e
r
a
t
i
o
n
r
e
m
o
d
e
l
l
i
n
g
b
i
o
m
e
s
h
i
s
s
a
f
e
i
n
a
l
l
b
u
t
t
h
e
m
o
s
t
p
u
r
u
l
e
n
t
o
f
w
o
u
n
d
s
.
M
i
n
i
m
i
s
e
t
h
e
“
c
o
m
p
l
i
a
n
c
e
m
i
s
-
m
a
t
c
h
”
b
e
t
w
e
e
n
m
e
s
h
a
n
d
n
a
t
i
v
e
t
i
s
s
u
e
M
e
s
h
w
e
i
g
h
t
,
s
t
i
f
f
n
e
s
s
a
n
d
c
o
n
s
t
r
u
c
t
i
o
n
m
u
s
t
s
u
i
t
t
i
s
s
u
e
r
e
s
i
l
i
e
n
c
e
a
t
t
h
e
s
u
r
g
i
c
a
l
s
i
t
e
,
a
n
d
t
h
e
d
e
g
r
e
e
o
f
m
o
v
e
m
e
n
t
e
x
p
e
c
t
e
d
a
t
t
h
e
g
r
a
f
t
–
h
o
s
t
i
n
t
e
r
f
a
c
e
.
I
n
g
r
o
i
n
h
e
r
n
i
a
,
l
o
w
w
e
i
g
h
t
,
m
a
c
r
o
p
o
r
o
u
s
,
m
o
n
o
f
i
l
a
m
e
n
t
,
p
o
l
y
p
r
o
p
y
l
e
n
e
(
A
m
i
d
t
y
p
e
1
)
m
e
s
h
e
s
h
a
v
e
w
o
r
k
e
d
w
e
l
l
,
b
u
t
t
h
e
s
e
s
a
m
e
m
a
t
e
r
i
a
l
s
a
r
e
l
e
s
s
a
p
p
r
o
p
r
i
a
t
e
f
o
r
t
h
e
g
e
n
i
t
a
l
t
r
a
c
t
.
C
h
o
i
c
e
o
f
m
e
s
h
m
u
s
t
s
u
i
t
s
u
r
g
i
c
a
l
o
b
j
e
c
t
i
v
e
s
I
n
p
l
a
n
n
i
n
g
t
h
e
s
u
r
g
e
r
y
,
t
h
e
e
x
a
c
t
r
e
a
s
o
n
w
h
y
a
n
i
m
p
l
a
n
t
i
s
b
e
i
n
g
u
s
e
d
m
u
s
t
b
e
a
c
l
e
a
r
l
y
d
e
f
i
n
e
d
o
b
j
e
c
t
i
v
e
.
I
n
p
a
r
t
i
c
u
l
a
r
,
t
h
e
s
u
r
g
e
o
n
m
u
s
t
d
i
f
f
e
r
e
n
t
i
a
t
e
b
e
t
w
e
e
n
u
s
i
n
g
t
h
e
m
e
s
h
a
s
a
n
e
o
l
i
g
a
m
e
n
t
(
i
n
w
h
i
c
h
c
a
s
e
,
t
h
e
i
m
p
l
a
n
t
w
i
l
l
b
e
s
u
b
j
e
c
t
e
d
t
o
s
t
r
o
n
g
s
t
a
t
i
c
f
o
r
c
e
s
)
v
e
r
s
u
s
u
s
i
n
g
t
h
e
m
e
s
h
a
s
a
b
r
i
d
g
i
n
g
g
r
a
f
t
(
i
n
w
h
i
c
h
c
a
s
e
,
t
h
e
i
m
p
l
a
n
t
w
i
l
l
b
e
s
u
b
j
e
c
t
e
d
t
o
r
e
p
e
t
i
t
i
v
e
d
y
n
a
m
i
c
f
o
r
c
e
s
)
.
M
e
s
h
i
m
p
l
a
n
t
m
u
s
t
o
v
e
r
l
a
p
t
h
e
d
e
f
e
c
t
o
n
a
l
l
s
i
d
e
s
T
h
e
s
i
z
e
a
n
d
s
h
a
p
e
m
e
s
h
m
u
s
t
b
e
s
u
f
f
i
c
i
e
n
t
t
o
c
o
m
p
l
e
t
e
l
y
c
o
v
e
r
t
h
e
h
e
r
n
i
a
l
d
e
f
e
c
t
,
a
n
d
t
o
o
v
e
r
l
a
p
s
t
r
o
n
g
t
i
s
s
u
e
o
n
a
l
l
s
i
d
e
s
.
A
s
a
r
u
l
e
o
f
t
h
u
m
b
,
h
e
r
n
i
a
s
u
r
g
e
o
n
s
h
a
v
e
u
s
u
a
l
l
y
r
e
g
a
r
d
e
d
a
n
o
v
e
r
l
a
p
o
f
3
–
5
c
m
a
s
s
u
f
f
i
c
i
e
n
t
.
S
t
a
b
i
l
i
s
e
a
g
a
i
n
s
t
d
o
u
b
l
i
n
g
,
w
r
i
n
k
l
i
n
g
&
u
n
d
u
e
s
h
r
i
n
k
a
g
e
T
h
e
m
e
s
h
m
u
s
t
b
e
a
n
c
h
o
r
e
d
w
i
t
h
i
n
t
e
r
r
u
p
t
e
d
p
e
r
m
a
n
e
n
t
s
u
t
u
r
e
s
,
t
o
p
r
e
v
e
n
t
s
u
b
s
e
q
u
e
n
t
i
n
f
l
a
m
m
a
t
o
r
y
r
e
a
c
t
i
o
n
f
r
o
m
s
h
r
i
n
k
i
n
g
t
h
e
m
e
s
h
o
r
f
r
o
m
w
r
i
n
k
l
i
n
g
i
t
i
n
t
o
a
p
a
i
n
f
u
l
m
a
s
s
(
a
“
m
e
s
h
o
m
a
”
)
.
M
e
s
h
m
u
s
t
b
e
p
l
a
c
e
d
i
n
a
t
e
n
s
i
o
n
-
f
r
e
e
m
a
n
n
e
r
G
y
n
a
e
c
o
l
o
g
i
s
t
s
h
a
v
e
m
i
s
i
n
t
e
r
p
r
e
t
e
d
t
h
e
t
e
r
m
“
t
e
n
s
i
o
n
-
f
r
e
e
”
t
o
m
e
a
n
n
o
t
s
u
t
u
r
i
n
g
a
n
i
m
p
l
a
n
t
t
o
a
d
j
a
c
e
n
t
t
i
s
s
u
e
s
.
T
h
i
s
i
s
a
n
i
m
p
o
r
t
a
n
t
e
r
r
o
r
.
T
h
e
c
o
r
r
e
c
t
s
u
r
g
i
c
a
l
m
e
a
n
i
n
g
i
s
t
h
a
t
t
h
e
m
e
s
h
m
u
s
t
b
e
k
e
p
t
m
e
s
h
l
o
o
s
e
(
t
o
a
l
l
o
w
f
o
r
s
u
b
s
e
q
u
e
n
t
c
o
n
t
r
a
c
t
u
r
e
)
,
a
n
d
s
h
a
p
e
d
i
n
t
o
a
s
l
i
g
h
t
b
o
w
l
-
l
i
k
e
c
u
r
v
a
t
u
r
e
i
n
t
o
t
h
e
m
e
s
h
(
t
o
a
l
l
o
w
f
o
r
i
n
c
r
e
a
s
e
d
p
o
s
t
u
r
a
l
t
o
n
e
w
h
e
n
t
h
e
p
a
t
i
e
n
t
i
s
a
m
b
u
l
a
t
o
r
y
)
.
T
h
e
i
m
p
l
a
n
t
i
s
t
h
e
n
s
e
c
u
r
e
d
a
g
a
i
n
s
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Int Urogynecol J (2011) 22:601–609 607dissection. Results improved with any form of augmenta-
tion. All 19 women in the synthetic mesh group had
successful anatomic outcomes, reflecting the tension-free
attributes and almost indestructible nature of synthetic
implants. However, severe mesh morbidity necessitated
removal of polypropylene prostheses in three women—
reducing ultimate surgical success to 84.2%. Use of
Surgisis
® ES, a resorbable tissue-inductive xenograft,
delivered the best results (92.1% 5-year anatomic success).
From a research perspective, pelvic reconstructive
surgeons do not appear to have grasped some profound
differences between the various biomaterials available for
prolapse repair. In essence, surgical implants are designed
to re-attach an avulsed structure to the body wall by
attracting the ingrowth of soft tissue. When considering
tissue augmentation, it is intuitive to select an inert
permanent material, such as synthetic mesh (e.g., polypro-
pylene and polyester). However, such prostheses always
evoke an acute foreign body inflammatory reaction [19].
Subsequent healing response is shaped by two main factors:
pore size/accessibility and device motion at the implanta-
tion site [20, 21]. Placing macroporous monofilament
(Amid Type I) mesh within immobile tissues generally
results in strong vascular and connective tissue ingrowth
(“incorporation”)[ 22]. However, poor fixation of an
implant can lead instead to excessive shearing stress against
host tissue, resulting in micro-bursa formation and poor
fixation [21]. Biomaterials scientists in the early 1990s
deliberately tanned various cadaveric and animal tissues
with glutaraldehyde or hexamethylene diisocyanate to delay
or permanently retard collagen turnover [23]. But “leathe-
rizing” these biological materials failed to produce the
“natural” scaffolds that manufacturers sought [8]. Clinical
outcomes were paradoxical. Graft-to-tissue bonding is
relatively weak, analogous to healing around a microporous
or multifilament (Amid Type II or III) synthetic mesh.
Moreover, there is a potential for subsequent graft autolysis,
leading to automatic support failure. FitzGerald et al. [24]
reported the failure of 45 of 67 (87%) Tutoplast
®
sacrocolpopexies and 14 of 35 (52%) Tutoplast
® slings.
Of 16 cases that came to abdominal re-exploration, 15
women had absent or inadequate graft material. Gandhi et
al. [25] found that an adjunct patch graft of Tutoplast
® did
not reduce the risk of recurrent Stage II cystocoele.
Similarly, in a prospective series of rectocele repair, Altman
et al. [26] had a 41% 3-year failure rate due to autolysis of
the implanted Pelvicol
® bridging graft. In contrast, prepar-
ing an acellular xenograft in a way that preserves both the
essential matrix molecules and a virtually intact protein
scaffold will evoke a ‘graft acceptance’ response (modulated
by Th2 lymphocytes and tissue-inductive M2 macrophages)
[9, 27, 28]. M2 macrophage infiltration leads to constructive
remodelling, rather than the familiar ‘graft rejection’ reaction
(modulated by Th1 lymphocytes and phagocytic M1 macro-
phages) that inevitably accompanies implantation of allo-
plasticmeshordenaturedcollagen.Tissue-inductiveimplants
are engineered to repopulate with host fibroblasts and
angioblasts within 2–3 weeks, then remodel into a strong
and self-renewable repair within 3–5 months. Hence,
programmed resorption of a second-generation biological
does notresultinrepairfailure.Rather,thisrapidresorptionis
the key reason why Surgisis
® ES evokes a constructive
remodelling M2 macrophage response. A slower resorption
rate would taint the wound with degenerating biomaterial,
thus potentially deviating healing towards the phagocytic
M1 macrophage response that produces chronic inflamma-
tion and late scar formation around synthetic mesh implants
[29, 30]. When implanting a bioactive graft, tissue quality of
the repair will depend on the cell source, the growth
modulating signals within the graft, the mechanical stresses
to which the healing wound is subject and host androgen
status [9].
Conclusions
Prolapse begins with intrapartum avulsion of the suspensory
visceral mesenteries from their skeletal anchor points, then
evolves to symptomatic descensus as host tissues weaken
over time. Durable repair appears to demand two things: that
the true site of support failure (i.e., the specific fascial tears,
not the secondary central bulges) be repaired without
tension and that degenerative tissue bordering the site of
the original fascial tear be rejuvenated with a tissue
augmentation material, appropriate to that implantation site.
Traditional anterior colporrhaphy addresses neither of these
surgical essentials. The fundamental objective of VPVR is to
rebuild the pubocervical septum from arcus to arcus and
from pubic ramus to pericervical ring. Suture-only techni-
ques satisfy the mechanical dictates of the hernia principles,
but not the metabolic ones. Conversely, use of an appropriate
bridging graft perhaps simplified the technical task of VPVR
and serendipitously rejuvenated adjacent connective tissue
(reducing late recurrence from 22.6% to 4.9%). It is intuitive
to choose an inert permanent material, such as synthetic
mesh or a denatured biological. Such prostheses always
attract phagocytic M1 macrophages, resulting in cicatrization.
Conversely, tissue engineering principles dictate that preserv-
ingnormalcollagenstructureandfunctioningmatrixmolecules
within an absorbable xenograft will attract M2 macrophages,
with constructive remodelling as the default healing response.
This explains how a temporary bridging graft can transform
into a permanent aponeurotic layer of host tissue, without the
potential for mesh pain or erosion. Thus, the 21.2%
improvement in 5-year durability attending xenograft-
augmented cystocoele repair is of considerable importance—
608 Int Urogynecol J (2011) 22:601–609especially since use of biomaterials made the operation
quicker and more readily standardised than VPVRs done
with native tissue. Prospective study is warranted.
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